Chase Pharmaceuticals Corporation inks $21 mln Series B
Chase Pharmaceuticals Corporation has raised a $21 million Series B financing led by New Rhein Healthcare Investors. Other new investors include Edmond de Rothschild Investment Partners and Cipla Ventures, the new venture capital arm of Cipla Pharmaceuticals.
12 May 2014•5 mins read
